Located in the hills west of the San Fernando Valley and northeast of the Santa Monica Mountains, Calabasas is California living at its finest.
Calabasas has long been rated as one of California’s most livable communities—complete with excellent education, prime real-estate, and easy access to nature.
But taking part in all that Calabasas has to offer isn’t easy when dealing with depression.
Which is why we’ve opened Achieve TMS Calabasas.
Our depression treatment center proudly offers the revolutionary dTMS therapy (deep transcranial magnetic stimulation)—a FDA-approved and highly effective form of depression treatment.
As the country’s largest TMS therapy providers, we’ve helped more than 600 patients free themselves from the pain of depression.
Transcranial magnetic stimulation is free of drugs or anesthesia, our TMS treatments give you the powerful but quick treatment you need to get on with your day.
During your 20-minute TMS depression treatments you will receive a series of short magnetic pulses delivered to the limbic system or mood center of the brain.
TMS Treatments are pain-free and many patients begin to see results within as little as two weeks.*
Achieve TMS is America’s largest provider of deep TMS therapy for the treatment for depression. Stop the despair. Take the next step. Regain joy.
Give us a call at 877-447-6503 for a free consultation or email us at firstname.lastname@example.org to learn more.
Please use ER or call 911 for emergency and contact your insurance provider for additional resources and contacts for covered providers.
So far, within California, Transcranial Magnetic Stimulation has been approved for use in treatment-resistant depression by Anthem Blue Cross/ Blue Shield, Humana, United Health Care, Healthnet, Tricare and more. Please call us for a list of providers. We would be happy to help check with your insurance provider regarding pre-approval.
*Different people with various diagnoses are helped to differing degrees. Results vary. Official FDA Approval is currently restricted to depression but several other uses are awaiting approval.